LifeStance Health Group, Inc.

NASDAQ:LFST

5.15 (USD) • At close June 27, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 332.97325.48312.722312.331300.437280.603262.895259.578252.589229.36217.56209.527203.095189.995173.835160.549143.132118.121101.98245.45373.106
Cost of Revenue 223.179216.044212.291233.125228.275219.506186.686186.607182.987166.668157.267149.697148.893135.745121.783109.34199.13479.14268.84731.27551.634
Gross Profit 109.79194.765100.43179.20672.16261.09776.20972.97169.60262.69260.29359.8354.20254.2552.05251.20843.99838.97933.13514.17821.472
Gross Profit Ratio 0.330.2910.3210.2540.240.2180.290.2810.2760.2730.2770.2860.2670.2860.2990.3190.3070.330.3250.3120.294
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 94.43193.70685.26995.15388.93493.368130.945101.85484.62689.81781.248103.559103.369152.652162.94385.47932.65123.66519.5348.64213.662
Selling & Marketing Expenses 000-0.381-0.095-0.9830008.6320001.9420002.605000
SG&A 94.43193.70685.26994.77288.83992.385130.945101.85484.62689.81781.248103.559103.369152.652162.94385.47932.65123.66519.5348.64213.662
Other Expenses 13.756015.115-0.004-0.074-0.042-0.001-0.02419.06918.88717.88416.74315.68415.35713.77712.77412.228-0.19710.915.4322.175
Operating Expenses 108.187108.377100.38494.77288.83992.385150.566121.384103.695108.70499.132120.302119.053168.009176.7298.25344.87935.03330.44414.07415.837
Operating Income 1.6041.0590.047-15.566-16.677-31.288-74.357-48.413-34.093-46.012-38.839-60.472-64.851-115.036-124.668-47.045-0.8813.9462.6910.1045.635
Operating Income Ratio 0.0050.0030-0.05-0.056-0.112-0.283-0.187-0.135-0.201-0.179-0.289-0.319-0.605-0.717-0.293-0.0060.0330.0260.0020.077
Total Other Income Expenses Net -3.074-9.935-5.429-6.674-3.962-6.045-3.611-3.607-4.186-7.704-3.367-7.332-4.153-4.879-4.535-26.776-10.562-11.013-7.059-5.816-2.279
Income Before Tax -1.47-8.876-5.382-22.621-20.734-38.316-77.968-52.02-38.279-53.716-42.206-67.804-69.004-118.638-129.203-73.821-11.443-7.067-4.368-5.7123.356
Income Before Tax Ratio -0.004-0.027-0.017-0.072-0.069-0.137-0.297-0.2-0.152-0.234-0.194-0.324-0.34-0.624-0.743-0.46-0.08-0.06-0.043-0.1260.046
Income Tax Expense -2.179-1.7640.5750.6560.3636.643-16.385-6.542-4.037-7.06-4.3530.923-6.676-10.608-8.751-3.788-2.761-1.578-1.074-1.370.703
Net Income 0.709-7.112-5.957-23.277-21.097-44.959-61.583-45.478-34.242-46.656-37.853-68.727-62.328-108.03-120.452-70.033-8.682-5.489-3.294-4.3422.208
Net Income Ratio 0.002-0.022-0.019-0.075-0.07-0.16-0.234-0.175-0.136-0.203-0.174-0.328-0.307-0.569-0.693-0.436-0.061-0.046-0.032-0.0960.03
EPS 0.002-0.019-0.016-0.061-0.056-0.12-0.17-0.13-0.095-0.12-0.11-0.19-0.18-0.33-0.35-0.22-0.023-0.018-0.009-0.0120.006
EPS Diluted 0.002-0.019-0.016-0.061-0.056-0.12-0.17-0.13-0.095-0.12-0.11-0.19-0.18-0.33-0.35-0.22-0.023-0.018-0.009-0.0120.006
EBITDA 9.21315.19115.1461.8027.733-10.567-52.87-27.371-14.118-29.664-20.133-43.928-49.879-99.679-111.923-34.2719.41715.31412.9635.2827.81
EBITDA Ratio 0.0280.0470.0480.0060.026-0.038-0.201-0.105-0.056-0.129-0.093-0.21-0.246-0.525-0.644-0.2130.0660.130.1270.1160.107